SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001479290-18-000106
Filing Date
2018-11-01
Accepted
2018-11-01 16:10:46
Documents
3
Period of Report
2018-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K rvncq318er8-k.htm 8-K 25654
2 EXHIBIT 99.1 rvncq318exhibit991.htm EX-99.1 164043
3 newlogotaglinea01.jpg GRAPHIC 29677
  Complete submission text file 0001479290-18-000106.txt   231897
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 181153870
SIC: 2834 Pharmaceutical Preparations